Gainers
- Carmell CTCX stock rose 31.0% to $0.46 during Wednesday's after-market session. The company's market cap stands at $9.6 million.
- Processa Pharma PCSA shares rose 30.07% to $1.73. The market value of their outstanding shares is at $5.6 million.
- China Pharma Holdings, Inc. Common Stock CPHI stock rose 8.83% to $0.28.
- Eagle Pharmaceuticals EGRX shares increased by 7.94% to $2.31. The market value of their outstanding shares is at $29.9 million.
- Bone Biologics BBLG stock moved upwards by 7.89% to $1.64. The company's market cap stands at $2.9 million.
- Conduit Pharmaceuticals CDT shares increased by 7.36% to $0.1. The market value of their outstanding shares is at $9.7 million.
Losers
- Soligenix SNGX stock declined by 8.6% to $4.45 during Wednesday's after-market session. The company's market cap stands at $10.1 million.
- Inspire Veterinary IVP shares fell 6.34% to $0.28. The company's market cap stands at $2.1 million.
- Kairos Pharma KAPA stock decreased by 5.3% to $1.25. The company's market cap stands at $16.0 million.
- Gossamer Bio GOSS stock declined by 4.77% to $1.0. The market value of their outstanding shares is at $226.2 million.
- Fractyl Health GUTS shares fell 4.75% to $2.21. The market value of their outstanding shares is at $105.9 million.
- TNF Pharmaceuticals TNFA shares fell 4.66% to $1.64. The market value of their outstanding shares is at $3.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
CDTConduit Pharmaceuticals Inc
$2.43-4.81%
CPHIChina Pharma Holding Inc
$0.2310-4.66%
CTCXCarmell Corp
$0.4129-3.41%
EGRXEagle Pharmaceuticals Inc
$0.8000-%
GOSSGossamer Bio Inc
$1.026.36%
GUTSFractyl Health Inc
$1.80-6.96%
IVPInspire Veterinary Partners Inc
$2.60-3.35%
KAPAKairos Pharma Ltd
$1.45-2.03%
PCSAProcessa Pharmaceuticals Inc
$0.6298-3.83%
SNGXSoligenix Inc
$2.28-1.30%
TNFATNF Pharmaceuticals Inc
$0.90011.26%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in